- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Moderate to Severe COVID-19 in Canada
Total 396 results
-
Merz North America, Inc.CompletedModerate to Severe Midface Volume DeficitCanada
-
Merz Pharmaceuticals GmbHCompletedModerate to Severe Glabellar Frown LinesUnited States, Canada
-
KLOX Technologies Inc.CompletedModerate to Severe Chronic PeriodontitisCanada
-
UCB Biopharma SRLActive, not recruitingModerate to Severe Plaque PsoriasisUnited States, Canada, Germany, Poland
-
Boston PharmaceuticalsCompletedModerate to Severe Acne VulgarisUnited States, Canada
-
Kythera BiopharmaceuticalsCompletedModerate or Severe Submental FullnessAustralia, Canada, United Kingdom
-
TakedaNimbus Lakshmi, Inc.; Innovaderm Research Inc.CompletedModerate to Severe Plaque PsoriasisUnited States, Canada
-
Kythera BiopharmaceuticalsCompletedPhase 1-2 Study of Deoxycholic Acid Injection (ATX-101) for the Reduction of Submental Fat (ATX-101)Moderate or Severe Submental FullnessUnited Kingdom, Canada, Australia
-
AbbVie (prior sponsor, Abbott)CompletedModerate to Severe Plaque PsoriasisUnited States, Austria, Belgium, Canada, Denmark, Finland, France, Germany, Greece, Italy, Spain, Sweden, Switzerland, United Kingdom
-
Bausch Health Americas, Inc.TerminatedModerate to Severe Plaque PsoriasisUnited States, Austria, France, Poland, Australia, Czechia, Canada, Hungary, Portugal, Spain, Netherlands
-
Novartis PharmaceuticalsCompletedModerate to Severe Plaque-type PsoriasisGermany, United States, Estonia, France, Canada
-
Novartis PharmaceuticalsCompletedModerate to Severe Palmoplantar PsoriasisBelgium, United States, Hungary, Russian Federation, Turkey, Australia, Israel, Netherlands, Portugal, Spain, United Kingdom, Norway, Slovakia, Canada, Finland
-
Sun Pharmaceutical Industries LimitedRecruitingModerate-to-severe Chronic Plaque PsoriasisUnited States, Hungary, India, Poland, Slovakia, Spain
-
Novartis PharmaceuticalsCompletedModerate to Severe Plaque-type PsoriasisUnited States, Czech Republic, Austria, Germany, India, Japan, Bulgaria, Singapore, Switzerland, United Kingdom, Italy, France, Poland, Slovakia, Canada, Vietnam
-
Royal Victoria Hospital, CanadaNot yet recruitingModerate to Severe Opioid Use DisorderCanada
-
Regenera Pharma LtdSyneos HealthCompletedHealthy Volunteers | Moderate to Severe Alzheimer PatientsCanada
-
Novartis PharmaceuticalsCompletedModerate to Severe Plaque-type PsoriasisGermany, United States, Belgium, Colombia, Spain, Estonia, Hungary, Japan, Lithuania, Taiwan, Australia, Korea, Republic of, Canada, Singapore, Italy, Israel, Sweden, Guatemala, United Kingdom, Argentina, France, Poland, Latvia, Iceland, Finla... and more
-
University Health Network, TorontoCompletedModerately Difficult to IntubateCanada
-
UCB Biopharma SRLCompletedModerate to Severe Chronic Plaque Psoriasis | Chronic Plaque PsoriasisUnited States, Canada
-
Novartis PharmaceuticalsCompletedModerate to Severe Chronic Plaque-Type PsoriasisUnited States, Germany, Japan, Bulgaria, Czechia, Singapore, Switzerland, United Kingdom, Italy, France, Vietnam, Poland, Slovakia, Austria, Canada
-
UCB Biopharma SRLCompletedModerate to Severe Plaque Psoriasis | Chronic Plaque PsoriasisUnited States, Australia, Canada, Germany, Hungary, Korea, Republic of, Poland, Russian Federation, Taiwan
-
Novartis PharmaceuticalsCompletedModerate to Severe Plaque-type PsoriasisUnited States, Colombia, Estonia, Japan, Taiwan, Israel, Canada, Lithuania, Argentina, Latvia, Iceland, Mexico
-
Fresenius Kabi SwissBioSim GmbHMerck KGaA, Darmstadt, GermanyCompletedPsoriasis | Moderate to Severe Plaque Psoriasis | Plaque Type PsoriasisUnited States, Canada, Czechia, Hungary, Russian Federation, Bulgaria, Mexico, United Kingdom, Poland, Germany, Estonia, France
-
Kythera BiopharmaceuticalsCompletedModerate or Severe Submental FullnessUnited States, Canada
-
Kythera BiopharmaceuticalsCompletedModerate or Severe Submental FullnessUnited States, Canada
-
UCB Biopharma SRLCompletedModerate to Severe Chronic Plaque Psoriasis | Chronic Plaque PsoriasisUnited States, Australia, Belgium, Canada, France, Germany, Netherlands, Poland, Spain, Turkey, United Kingdom
-
Ottawa Hospital Research InstituteUnknownBereavement | Severe Grief ReactionCanada
-
Novartis PharmaceuticalsCompletedModerate to Severe Chronic Plaque-type PsoriasisUnited States, Hungary, Italy, Russian Federation, Germany, Czechia, Canada
-
UCB Biopharma SRLCompletedModerate to Severe Chronic Plaque Psoriasis | Chronic Plaque PsoriasisUnited States, Australia, Belgium, Canada, Germany, Hungary, Italy, Japan, Korea, Republic of, Poland, Russian Federation, Taiwan, United Kingdom
-
Indivior Inc.Active, not recruitingModerate to Severe Opioid-use DisorderUnited States, Canada
-
AmgenTerminatedModerate to Severe Rheumatoid ArthritisUnited States, Canada, Puerto Rico
-
Incyte CorporationRecruitingModerate to Severe AsthmaKorea, Republic of, United States, Spain, Poland, Japan, Canada, Germany, Belgium, Argentina
-
Humanigen, Inc.CompletedModerate-to-Severe AsthmaFrance, United Kingdom, United States, Australia, Poland, Ukraine
-
The Hospital for Sick ChildrenRecruitingObstructive Sleep Apnea | Obstructive Sleep Apnea (Moderate to Severe)Canada
-
SanofiRegeneron PharmaceuticalsRecruitingModerate to Severe Atopic DermatitisCanada
-
Inmagene LLCTerminatedAtopic Dermatitis | Moderate-to-severe Atopic Dermatitis | ADCanada, United States
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease | COPD | Moderate to Very Severe COPDUnited States, Canada
-
University of SaskatchewanGovernment of Canada; Government of SaskatchewanActive, not recruitingSevere Acute Respiratory Syndrome Coronavirus 2 InfectionCanada
-
Laval UniversityCISSS de Chaudière-Appalaches; VITAM: Research Center on Sustainable Health; Centre... and other collaboratorsRecruiting
-
Lucid, Inc.CompletedMild to Moderate DementiaCanada
-
University Health Network, TorontoRecruitingLong COVID | Post Acute Sequelae of COVID-19 | Post COVID ConditionCanada
-
GAAD Medical Research Institute Inc.WithdrawnCovid-19 InfectionsCanada
-
Entos Pharmaceuticals Inc.Q2 Solutions; Calian CRO; PCI Pharma ServicesNot yet recruiting
-
St. Joseph's Healthcare HamiltonTimothy O'Shea; Marek Smieja; Lawrence MbuagbawUnknown
-
McGill University Health Centre/Research Institute...Canadian Institutes of Health Research (CIHR); RESPIPLUS; Santé WillKin (WillKin... and other collaboratorsActive, not recruitingCOVID-19 | Long COVID | Post COVID-19Canada
-
AstraZenecaMedImmune LLCCompletedModerate to Very Severe Chronic Obstructive Pulmonary DiseaseUnited States, Canada, Germany, Italy, Netherlands, Spain, United Kingdom, Poland, Japan, Austria, Korea, Republic of, Russian Federation, South Africa, Czechia, Hungary, Romania, Switzerland
-
AmgenActive, not recruitingAtopic Dermatitis | Moderate-to-severe Atopic DermatitisUnited States, Canada
-
Nektar TherapeuticsRecruitingModerate to Severe Atopic DermatitisUnited States, Australia, Canada
-
Louis BhererCompletedCOVID-19 Respiratory InfectionCanada
-
UCB Biopharma SRLCompletedPsoriatic Arthritis | Moderate to Severe Chronic Plaque Psoriasis | Chronic Plaque PsoriasisUnited States, Australia, Canada, Germany, Hungary, Korea, Republic of, Poland, Russian Federation, United Kingdom